C/EBPβ Binds the P1 Promoter of the Runx2 Gene and Up-regulates Runx2 Transcription in Osteoblastic Cells

Overview

Journal J Cell Physiol

Specialties Cell Biology
Physiology

Date 2011 Feb 9

PMID 21302301

Citations 21

Authors

Berta Henriquez

Matias Hepp

Paola Merino

Hugo Sepulveda

Andre J van Wijnen

Jane B Lian

Gary S Stein

Janet L Stein

Martin Montecino

Affiliations

Soon will be listed here.

Abstract

The Runx2 factor is an essential component of the regulatory mechanisms that control transcription during skeletogenesis. Runx2/p57 expression in osteoblastic cells is controlled by the P1 promoter, which is recognized by key regulators of osteoblast differentiation including homeodomain factors and Wnt- and BMP-signaling mediators. Here, we report that the transcription factor C/EBPβ up-regulates Runx2/p57 expression by directly binding to the Runx2 P1 promoter in mesenchymal, pre-osteoblastic, and osteoblastic cells. This C/EBPβ-mediated up-regulation is principally dependent on C/EBP site II that is located within the first 180 bp of the proximal P1 promoter region and is highly conserved among mouse, rat, and human Runx2 genes. Our studies reveal how the C/EBPβ factor, known to have a key role during osteogenesis, contributes to regulating the expression of Runx2, the master regulator of osteoblast differentiation.

Citing Articles

CCAAT/Enhancer-Binding Protein β (C/EBPβ) Regulates Calcium Deposition in Smooth Muscle Cells.

Choe N, Shin S, Kim Y, Kook H, Kwon D Int J Mol Sci. 2025; 25(24.

PMID: 39769429 PMC: 11728292. DOI: 10.3390/ijms252413667.

Cell signaling and transcriptional regulation of osteoblast lineage commitment, differentiation, bone formation, and homeostasis.

Zhu S, Chen W, Masson A, Li Y Cell Discov. 2024; 10(1):71.

PMID: 38956429 PMC: 11219878. DOI: 10.1038/s41421-024-00689-6.

Circ_0087960 stabilizes KDM5B by reducing SKP2 mediated ubiquitination degradation and promotes osteogenic differentiation in periodontal ligament stem cells.

Liu Y, Zhou Y Regen Ther. 2022; 19:122-130.

PMID: 35229010 PMC: 8844145. DOI: 10.1016/j.reth.2022.01.003.

Characterization of Gene Isoforms and Targets Across Cell Types Reveals Highly Conserved Networks.

Farkas C, Quiroz A, Alvarez C, Hermosilla V, Aylwin C, Lomniczi A Front Genet. 2021; 12:613808.

PMID: 33692826 PMC: 7937961. DOI: 10.3389/fgene.2021.613808.

TGFβ1 Suppressed Matrix Mineralization of Osteoblasts Differentiation by Regulating SMURF1-C/EBPβ-DKK1 Axis.

Nam B, Park H, Lee Y, Oh Y, Park J, Kim S Int J Mol Sci. 2020; 21(24).

PMID: 33371439 PMC: 7767413. DOI: 10.3390/ijms21249771.

References

Kowenz-Leutz E, Pless O, Dittmar G, Knoblich M, Leutz A . Crosstalk between C/EBPbeta phosphorylation, arginine methylation, and SWI/SNF/Mediator implies an indexing transcription factor code. EMBO J. 2010; 29(6):1105-15. PMC: 2845275. DOI: 10.1038/emboj.2010.3. View

Otto F, Thornell A, Crompton T, Denzel A, Gilmour K, Rosewell I . Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 1997; 89(5):765-71. DOI: 10.1016/s0092-8674(00)80259-7. View

Shen Q, Christakos S . The vitamin D receptor, Runx2, and the Notch signaling pathway cooperate in the transcriptional regulation of osteopontin. J Biol Chem. 2005; 280(49):40589-98. DOI: 10.1074/jbc.M504166200. View

Gaur T, Lengner C, Hovhannisyan H, Bhat R, Bodine P, Komm B . Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem. 2005; 280(39):33132-40. DOI: 10.1074/jbc.M500608200. View

Shin C, Jeon M, Yang J, Her S, Kim D, Kim S . CCAAT/enhancer-binding protein delta activates the Runx2-mediated transcription of mouse osteocalcin II promoter. J Mol Endocrinol. 2006; 36(3):531-46. DOI: 10.1677/jme.1.01944. View

Chen J, Zhao M, Rao R, Inoue H, Hao C . C/EBP{beta} and its binding element are required for NF{kappa}B-induced COX2 expression following hypertonic stress. J Biol Chem. 2005; 280(16):16354-9. DOI: 10.1074/jbc.M411134200. View

Sierra J, Villagra A, Paredes R, Cruzat F, Gutierrez S, Javed A . Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity. Mol Cell Biol. 2003; 23(9):3339-51. PMC: 153185. DOI: 10.1128/MCB.23.9.3339-3351.2003. View

Soutoglou E, Talianidis I . Coordination of PIC assembly and chromatin remodeling during differentiation-induced gene activation. Science. 2002; 295(5561):1901-4. DOI: 10.1126/science.1068356. View

Shirakawa K, Maeda S, Gotoh T, Hayashi M, Shinomiya K, Ehata S . CCAAT/enhancer-binding protein homologous protein (CHOP) regulates osteoblast differentiation. Mol Cell Biol. 2006; 26(16):6105-16. PMC: 1592788. DOI: 10.1128/MCB.02429-05. View

10.

Lee M, Kim Y, Yoon W, Kim J, Kim B, Hwang Y . Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter. J Biol Chem. 2005; 280(42):35579-87. DOI: 10.1074/jbc.M502267200. View

11.

Mink S, Haenig B, Klempnauer K . Interaction and functional collaboration of p300 and C/EBPbeta. Mol Cell Biol. 1997; 17(11):6609-17. PMC: 232514. DOI: 10.1128/MCB.17.11.6609. View

12.

Drissi H, Luc Q, Shakoori R, Chuva De Sousa Lopes S, Choi J, Terry A . Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene. J Cell Physiol. 2000; 184(3):341-50. DOI: 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z. View

13.

Hassan M, Tare R, Lee S, Mandeville M, Morasso M, Javed A . BMP2 commitment to the osteogenic lineage involves activation of Runx2 by DLX3 and a homeodomain transcriptional network. J Biol Chem. 2006; 281(52):40515-26. DOI: 10.1074/jbc.M604508200. View

14.

Gutierrez S, Javed A, Tennant D, van Rees M, Montecino M, Stein G . CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. J Biol Chem. 2001; 277(2):1316-23. DOI: 10.1074/jbc.M106611200. View

15.

Hassan M, Tare R, Lee S, Mandeville M, Weiner B, Montecino M . HOXA10 controls osteoblastogenesis by directly activating bone regulatory and phenotypic genes. Mol Cell Biol. 2007; 27(9):3337-52. PMC: 1899966. DOI: 10.1128/MCB.01544-06. View

16.

Ramji D, Foka P . CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J. 2002; 365(Pt 3):561-75. PMC: 1222736. DOI: 10.1042/BJ20020508. View

17.

Wiper-Bergeron N, St-Louis C, Lee J . CCAAT/Enhancer binding protein beta abrogates retinoic acid-induced osteoblast differentiation via repression of Runx2 transcription. Mol Endocrinol. 2007; 21(9):2124-35. DOI: 10.1210/me.2006-0452. View

18.

Villagra A, Cruzat F, Carvallo L, Paredes R, Olate J, van Wijnen A . Chromatin remodeling and transcriptional activity of the bone-specific osteocalcin gene require CCAAT/enhancer-binding protein beta-dependent recruitment of SWI/SNF activity. J Biol Chem. 2006; 281(32):22695-706. DOI: 10.1074/jbc.M511640200. View

19.

Dhawan P, Peng X, Sutton A, MacDonald P, Croniger C, Trautwein C . Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase. Mol Cell Biol. 2004; 25(1):472-87. PMC: 538756. DOI: 10.1128/MCB.25.1.472-487.2005. View

20.

Harrison J, Huang Y, Wilson K, Kelly P, Adams D, Gronowicz G . Col1a1 promoter-targeted expression of p20 CCAAT enhancer-binding protein beta (C/EBPbeta), a truncated C/EBPbeta isoform, causes osteopenia in transgenic mice. J Biol Chem. 2004; 280(9):8117-24. DOI: 10.1074/jbc.M410076200. View